Alembic Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,027	834.8	1,202	754.8	610.9
Cash & Short-Term Investments	2,027	834.8	1,202	754.8	610.9
Cash Growth	142.81%	-30.55%	59.26%	23.55%	-78.57%
Accounts Receivable	14,663	13,998	10,248	10,464	8,071
Other Receivables	106.8	110.1	477.5	827.1	250.8
Receivables	14,770	14,108	10,726	11,291	8,322
Inventory	25,106	22,881	16,435	14,753	16,097
Prepaid Expenses	-	691.8	500.5	553.2	370.7
Other Current Assets	3,823	2,362	1,922	1,748	3,207
Total Current Assets	45,726	40,878	30,786	29,100	28,608
Property, Plant & Equipment	34,773	33,608	30,711	29,997	39,473
Long-Term Investments	1,409	1,272	930.2	963.3	1,184
Other Intangible Assets	2,868	-	-	-	1,548
Long-Term Deferred Tax Assets	2,696	1,660	1,696	1,230	58.8
Other Long-Term Assets	154.4	311.5	332.9	537.4	348.8
Total Assets	87,626	77,729	64,456	61,828	71,220
Accounts Payable	8,351	8,799	7,356	6,798	7,064
Accrued Expenses	-	1,828	1,582	1,418	1,850
Short-Term Debt	-	11,956	4,305	6,359	4,300
Current Portion of Long-Term Debt	12,389	-	-	-	2,000
Current Portion of Leases	243.3	151.6	198.3	169.2	149.8
Current Income Taxes Payable	349.8	189.1	-	-	-
Current Unearned Revenue	-	115.6	114.5	112.7	123.6
Other Current Liabilities	4,605	1,085	994.2	1,512	1,678
Total Current Liabilities	25,938	24,123	14,550	16,369	17,165
Long-Term Debt	1,219	-	-	-	-
Long-Term Leases	447.6	467.7	628.8	692.3	721.4
Pension & Post-Retirement Benefits	-	270.9	90.2	57.2	-
Other Long-Term Liabilities	3,331	972.2	1,005	1,005	958.1
Total Liabilities	30,936	25,834	16,274	18,124	18,845
Common Stock	393.1	393.1	393.1	393.1	393.1
Additional Paid-In Capital	-	7,484	7,484	7,484	7,484
Retained Earnings	-	43,945	40,273	35,687	43,991
Comprehensive Income & Other	56,355	87.8	32.4	140.8	507.2
Total Common Equity	56,748	51,909	48,182	43,705	52,376
Minority Interest	-58.3	-14.2	-	-	-
Shareholders' Equity	56,690	51,895	48,182	43,705	52,376
Total Liabilities & Equity	87,626	77,729	64,456	61,828	71,220
Total Debt	14,299	12,575	5,132	7,220	7,171
Net Cash (Debt)	-12,272	-11,740	-3,930	-6,465	-6,560
Net Cash Per Share	-62.44	-59.73	-19.99	-32.89	-33.37
Filing Date Shares Outstanding	196.61	196.56	196.56	196.56	196.56
Total Common Shares Outstanding	196.61	196.56	196.56	196.56	196.56
Working Capital	19,788	16,755	16,236	12,731	11,443
Book Value Per Share	288.64	264.09	245.12	222.34	266.46
Tangible Book Value	53,880	51,909	48,182	43,705	50,827
Tangible Book Value Per Share	274.05	264.09	245.12	222.34	258.58
Land	-	1,070	1,013	1,017	931.4
Buildings	-	7,810	7,465	7,068	5,277
Machinery	-	30,646	28,487	24,961	18,291
Construction In Progress	-	8,372	5,244	6,013	22,058
Leasehold Improvements	-	36	18.3	7.9	7.3